📖
α-Lipoic Acid, with or Without Ambrisentan, Attenuates Experimental Pulmonary Arterial Hypertension: Associations with AMPK/mTOR/NF-κB Signaling and Kallistatin.
Ayik S, Huz M, Ulutas Z, Balkar ME, Tanbek K, Sonmez R, Unal RU, Karadag E, Baydak S, Tanriverdi LH, Ozhan O

α-Lipoic Acid, with or Without Ambrisentan, Attenuates Experimental Pulmonary Arterial Hypertension: Associations with AMPK/mTOR/NF-κB Signaling and Kallistatin.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Biomolecules.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title α-Lipoic Acid, with or Without Ambrisentan, Attenuates Experimental Pulmonary Arterial Hypertension: Associations with AMPK/mTOR/NF-κB Signaling and Kallistatin.
Author / Organization Ayik S, Huz M, Ulutas Z, Balkar ME, Tanbek K, Sonmez R, Unal RU, Karadag E, Baydak S, Tanriverdi LH, Ozhan O
Subject & Discipline Biomolecules
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-259216
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »